arBtrage CAPITALIZING MARKETS checking… Sign in

Pyxis Oncology, Inc.

PYXS Health Care Biotechnology: Pharmaceutical Preparations
$1.78
▲ +4.1% Today
as of Jun 7, 07:25 ET
Last 30 days +4.71% Apr 28 → Jun 05
$1.54 $1.87 $2.19 $2.51 $2.84 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.71
High
$1.87
Low
$1.62
Volume
$843,622
Avg Vol
$758,506
Mkt Cap
$113M
P/E (TTM)
Beta
52w High
$5.55
52w Low
$0.97
Div Yield
Shares Out
$63M

Overview

52-week range
$0.97
$5.55
18% of range
Avg surprise (last 2)
-13.2%
Avg reaction (last 2)
-6.0%
50% positive
Latest IV / EM
406%
EM ±56.2% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.56$-0.44$-0.31$-0.19$-0.06 Actual $-0.41Actual $-0.56Actual $-0.06Actual $-0.29Actual $-0.35Actual $-0.35Est $-0.29Actual $-0.30Actual $-0.35Actual $-0.37Est $-0.35 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-23M$-17M$-10M$-4M$3M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.37 $-0.35 -5.7% -5.7% -15.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.35 financials
Mon Jun 30, 2025Jun 2025 $-0.30 financials
Thu May 15, 2025Mar/2025 $-0.35 $-0.29 -20.7% +3.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.35 financials
Sun Jun 30, 2024Jun 2024 $-0.29 financials
Sun Mar 31, 2024Mar 2024 $-0.06 financials
Sat Sep 30, 2023Sep 2023 $-0.56 financials
Fri Jun 30, 2023Jun 2023 $-0.41 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$3M
Cost of revenue
Gross profit
Operating income$-24M$-23M$-20M$-23M$-24M$-20M
Net income$-23M$-22M$-18M$-21M$-21M$-17M
EPS (diluted)$-0.37$-0.35$-0.30$-0.35$-0.35$-0.29

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$6M$15M$9M$11M$13M$19M$12M$25M
Inventory
Total current assets$46M$72M$83M$100M$112M$132M$149M$161M
Total assets$64M$92M$106M$123M$136M$157M$195M$208M
Long-term debt
Total liabilities$33M$38M$37M$36M$33M$36M$42M$39M
Total equity$31M$53M$69M$88M$103M$121M$154M$170M

Implied volatility — last 90 days

400%403%405%408%410% Jun 07 — IV 406% · EM ±56.2%

Sector peers